Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RSSS
RSSS logo

RSSS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Research Solutions Inc (RSSS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.250
1 Day change
0.45%
52 Week Range
4.120
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Research Solutions Inc (RSSS) does not present a compelling buy opportunity for a long-term beginner investor at this time. The company's financial performance is weak, with declining revenue, net income, and EPS. Additionally, there are no strong technical or proprietary trading signals to support a buy decision. Analysts have lowered the price target, and there are no significant positive catalysts or influential trading activity to suggest upside potential in the near term.

Technical Analysis

The MACD is positive and expanding, indicating slight bullish momentum. RSI is neutral at 55.599, and moving averages are converging, suggesting no clear trend. Support and resistance levels indicate limited price movement, with the pre-market price of $2.30 near the pivot level of $2.291.

Positive Catalysts

  • Gross margin increased by 7.37% YoY, reflecting some operational efficiency improvements.

Neutral/Negative Catalysts

  • Revenue dropped by 1.02% YoY, net income plummeted by 127.62% YoY, and EPS fell by 128.57% YoY. Analysts lowered the price target from $6 to $5 due to revenue declines and churn in B2C segments. No significant hedge fund or insider trading activity, and no recent news or congress trading data.

Financial Performance

In 2026/Q2, revenue declined to $11,792,651 (-1.02% YoY), net income dropped to $546,919 (-127.62% YoY), and EPS fell to $0.02 (-128.57% YoY). However, gross margin improved to 49.7% (+7.37% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Maxim lowered the price target from $6 to $5 while maintaining a Buy rating. The analyst cited revenue declines and churn in B2C segments as key issues, despite cost controls and margin expansion.

Wall Street analysts forecast RSSS stock price to rise
3 Analyst Rating
Wall Street analysts forecast RSSS stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 2.240
sliders
Low
5
Averages
5.33
High
6
Current: 2.240
sliders
Low
5
Averages
5.33
High
6
Maxim
Maxim
Buy
downgrade
$6 -> $5
AI Analysis
2026-02-13
Reason
Maxim
Maxim
Price Target
$6 -> $5
AI Analysis
2026-02-13
downgrade
Buy
Reason
Maxim lowered the firm's price target on Research Solutions to $5 from $6 and keeps a Buy rating on the shares. The company's revenue was below estimates and consensus due to churn in B2C and declines in Transactions revenue, while adjusted EBITDA was in line with consensus and beat Maxim estimate due to cost controls and continued margin expansion, the analyst tells investors in a research note.
Roth Capital
Buy
maintain
$5
2025-09-19
Reason
Roth Capital
Price Target
$5
2025-09-19
maintain
Buy
Reason
Roth Capital raised the firm's price target on Research Solutions to $5 from $4.35 and keeps a Buy rating on the shares. The company pre-announced good Q4 results in mid-August, with core recurring platform revenues above the firm's forecast to largely offset soft transactions revenues, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for RSSS
Unlock Now

People Also Watch